AMCR vs CADL · P/E 18, rev $23.51B vs $592.0M cap
Amcor PLC (AMCR) versus Candel Therapeutics Inc (CADL) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
CADL does not have a complete income-statement cache yet.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. CADL currently screens at market cap $592.0M.
Not investment advice. Open the AMCR and CADL stock pages for the full models.
Not investment advice.